Safety of treatment with guselkumab in clinical trials for up to 5 years in patients with moderate-to-severe plaque psoriasis. . Br J Dermatol 2023;189:e29.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Safety of treatment with guselkumab in clinical trials for up to 5 years in patients with moderate-to-severe plaque psoriasis. Br J Dermatol 2023;189:e29.
PMID: 37418651